Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 3626  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
 
  NAVIGATE here  
  ::   Search
  ::   Ahead of print
  ::   Current Issue
  ::   Submit Article 
  ::   Apply as Referee 
  ::   JPGM WriteCon 
  ::   Current Symposium 

 


This article has been cited by
1Challenges facing community-dwelling adults with hemophilia: Implications for community-based adult education and nursing
Charity Chinelo Okide,Chiedu Eseadi,Uzoamaka Lucynda Koledoye,Felicia Mbagwu,Nwakaego Ebele Ekwealor,Nkechi Mercy Okeke,Chioma Osilike,Polycarp M.D. Okeke
Journal of International Medical Research.2020;48(1)030006051986210
[DOI]
2Effectiveness of Prophylactic Coagulation Factor Replacement Therapy in Patients with Severe Hemophilia A in Taiwan – A Population-Based Study
Miyuki Hsing-Chun Hsieh,Shyh-Shin Chiou,Tzu-Chi Liao,Shi-Jie Lai,Edward Chia-Cheng Lai
Clinical Epidemiology.2022;Volume 14(1)1501
[DOI]
3Economic burden of hemophilia A and B: a case in Iran
Khosro Keshavarz,Mohammadreza Bordbar,Zeinab Hashemipoor,Farideh Sadat Jalali,Ramin Ravangard
Hematology.2020;25(1)149
[DOI]
4Cost-of-illness studies in rare diseases: a scoping review
Lidia García-Pérez,Renata Linertová,Cristina Valcárcel-Nazco,Manuel Posada,Inigo Gorostiza,Pedro Serrano-Aguilar
Orphanet Journal of Rare Diseases.2021;16(1)149
[DOI]
5Genomics of rare genetic diseases—experiences from India
Sridhar Sivasubbu,Vinod Scaria
Human Genomics.2019;13(1)149
[DOI]
6Determination of reference intervals from a laboratory database of an academic clinical research unit in a tertiary care teaching hospital and an audit of out of range values
BrinalH Figer,JeffreyPradeep Raj,SaketJ Thaker,NithyaJaideep Gogtay,UrmilaMukund Thatte
Perspectives in Clinical Research.2021;12(4)193
[DOI]
7Cost-minimization analysis of recombinant factor VIII Fc versus emicizumab for treating patients with hemophilia A without inhibitors in Europe
Maria Elisa Mancuso,Giancarlo Castaman,Michal Pochopien,Samuel Aballéa,Aleksandra Drzewiecka,Zalmai Hakimi,Jameel Nazir,Francis Fatoye
Journal of Medical Economics.2022;25(1)1068
[DOI]
8Trends in coagulation factor replacement therapy and medical costs in patients with haemophilia in Taiwan: A population-based, 15-year analysis
Miyuki Hsing-Chun Hsieh,Shyh-Shin Chiou,Tzu-Chi Liao,Yea-Huei Kao Yang,Edward Chia-Cheng Lai
Haemophilia.2021;27(2)1068
[DOI]
Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow